Back to Search
Start Over
Protalix BioTherapeutics Secures French ATU for taliglucerase alfa for the Treatment of Gaucher Disease
- Source :
- Wireless News. July 16, 2010
- Publication Year :
- 2010
-
Abstract
- Protalix BioTherapeutics, Inc. has announced that the French regulatory authority has granted an Autorisation Temporaire d'Utilisation (ATU), or Temporary Authorization for Use, for taliglucerase alfa for the treatment of Gaucher [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Wireless News
- Publication Type :
- News
- Accession number :
- edsgcl.232693281